Citigroup’s Core Laboratories CLB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-5,000
Closed -$76K 7391
2020
Q3
$76K Sell
5,000
-1,400
-22% -$29.4K ﹤0.01% 5308
2020
Q2
$130K Buy
6,400
+700
+12% +$12.5K ﹤0.01% 5351
2020
Q1
$59K Sell
5,700
-1,100
-16% -$30.8K ﹤0.01% 5825
2019
Q4
$256K Buy
6,800
+4,600
+209% +$207K ﹤0.01% 4975
2019
Q3
$103K Buy
2,200
+600
+38% +$27.9K ﹤0.01% 5643
2019
Q2
$84K Buy
1,600
+700
+78% +$41.1K ﹤0.01% 6025
2019
Q1
$62K Sell
900
-300
-25% -$20.1K ﹤0.01% 6153
2018
Q4
$72K Sell
1,200
-9,500
-89% -$820K ﹤0.01% 5928
2018
Q3
$1.24M Buy
10,700
+9,300
+664% +$1.05M ﹤0.01% 3252
2018
Q2
$177K Buy
1,400
+1,000
+250% +$122K ﹤0.01% 5180
2018
Q1
$43K Sell
400
-6,700
-94% -$741K ﹤0.01% 6267
2017
Q4
$778K Sell
7,100
-5,700
-45% -$569K ﹤0.01% 3606
2017
Q3
$1.26M Buy
12,800
+9,300
+266% +$902K ﹤0.01% 3125
2017
Q2
$354K Buy
3,500
+3,000
+600% +$323K ﹤0.01% 4303
2017
Q1
$58K Sell
500
-2,000
-80% -$232K ﹤0.01% 5594
2016
Q4
$300K Sell
2,500
-1,700
-40% -$188K ﹤0.01% 4929
2016
Q3
$472K Buy
+4,200
New +$484K ﹤0.01% 3938
2016
Q2
Sell
-400
Closed -$45K 7103
2016
Q1
$45K Sell
400
-700
-64% -$72.7K ﹤0.01% 6162
2015
Q4
$120K Buy
+1,100
New +$126K ﹤0.01% 5221
2015
Q3
Sell
-100
Closed -$11K 7405
2015
Q2
$11K Buy
+100
New +$12.1K ﹤0.01% 6405

Other funds holding CLB

Citigroup's CLB Position: Q1 2026 in Review

Citigroup increased its Core Laboratories (CLB) stake by 174% in Q1 2026, buying an estimated $317K and bringing the position to 27,905 shares worth $469K. The position accounts for ﹤0.01% of the portfolio, ranked #3590.

Citigroup first reported a position in CLB in Q2 2013 and has held it in 52 quarters since. The position peaked at $15.9M in Q2 2018. 190 funds tracked by Wall St. Rank hold CLB as of Q1 2026.

  • Citigroup held 27,905 shares of Core Laboratories worth $469K as of Q1 2026.
  • Citigroup bought 17,709 Core Laboratories shares in Q1 2026, an estimated $317K.
  • Core Laboratories made up ﹤0.01% of Citigroup's portfolio in Q1 2026, its #3590 holding.
  • Citigroup first reported a position in Core Laboratories in Q2 2013 and has held it in 52 quarters since.
  • Citigroup's Core Laboratories position peaked at $15.9M in Q2 2018.
  • 190 funds tracked by Wall St. Rank held Core Laboratories as of Q1 2026.

Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.